-

Aptar Announces Passing of Director Jesse Wu

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR) today announced with deep sadness that Jesse Wu, a director of the Company, has passed away. Mr. Wu served on the Board of Directors since 2018 and was a member of the Management Development & Compensation Committee.

“Jesse was a valued member of our Board and wonderful colleague. We mourn his passing and extend our deepest condolences to his family. His warm personality and extensive experience will be greatly missed,” said George Fotiades, Chairman of the Board.

Stephan B. Tanda, Aptar President and CEO stated, “We were very fortunate to have had Jesse’s guidance over the past four years, especially his substantial knowledge of the consumer product and healthcare markets, and his valuable contributions to our strategy for the Asian region.”

About Aptar

Aptar is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions and services. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, personal care, home care, food and beverage. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective technologies for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com.

Contacts

Investor Relations Contact:
Matt DellaMaria
matt.dellamaria@aptar.com
815-479-5530

Media Contact:
Katie Reardon
katie.reardon@aptar.com
815-479-5671

AptarGroup, Inc.

NYSE:ATR

Release Versions

Contacts

Investor Relations Contact:
Matt DellaMaria
matt.dellamaria@aptar.com
815-479-5530

Media Contact:
Katie Reardon
katie.reardon@aptar.com
815-479-5671

More News From AptarGroup, Inc.

Aptar’s Nasal Vaccine Delivery Solutions Featured in CastleVax Phase II Clinical Trial of an Intranasal COVID-19 Vaccine Candidate

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar’s Nasal Vaccine Delivery Solutions Featured in CastleVax Phase II Clinical Trial of an Intranasal COVID-19 Vaccine Candidate...

Aptar’s Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar’s Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™...

Aptar Announces 2026 Quarterly Conference Call Dates

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Announces 2026 Quarterly Conference Call Dates...
Back to Newsroom